Understanding CAS 106092-11-9: The Building Block for Dopamine Agonist Therapies
In the realm of pharmaceutical development, understanding the foundational components of life-saving drugs is paramount. One such critical molecule is (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, designated by CAS number 106092-11-9. This chiral chemical intermediate is not merely a precursor but a vital building block in the synthesis of a class of drugs known as dopamine agonists, which are instrumental in treating a variety of neurological conditions.
Dopamine agonists are drugs that stimulate dopamine receptors in the brain, effectively mimicking the action of dopamine, a neurotransmitter crucial for motor control, motivation, and pleasure. Pramipexole, a prominent drug synthesized using CAS 106092-11-9, is a powerful example. It is widely prescribed for managing Parkinson's disease, a progressive neurodegenerative disorder that affects movement, and for treating restless legs syndrome, a neurological condition causing an irresistible urge to move the legs. The precise structure of (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole dictates the stereochemistry of Pramipexole, ensuring its targeted action on dopamine receptors.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to producing and supplying high-purity (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, understanding its critical role in these therapeutic areas. The chemical properties of this intermediate, including its specific molecular weight (169.25 g/mol) and its typically high purity (≥99.0%), are meticulously controlled to meet the exacting demands of pharmaceutical manufacturing. The ability to buy or purchase this intermediate reliably is key for companies developing next-generation dopamine agonist therapies.
The synthesis pathways utilizing CAS 106092-11-9 are complex, requiring specialized knowledge in organic chemistry and stereoselective synthesis. As a trusted manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. provides not only the chemical itself but also the assurance of quality and consistency that pharmaceutical clients depend on. This commitment underpins the development of safer and more effective treatments for patients suffering from conditions like Parkinson's disease.
For researchers and manufacturers exploring new therapeutic avenues or optimizing existing drug production, understanding the foundational role of intermediates like CAS 106092-11-9 is essential. Partnering with NINGBO INNO PHARMCHEM CO.,LTD. ensures access to a critical component that drives innovation in dopamine agonist therapies.
Dopamine agonists are drugs that stimulate dopamine receptors in the brain, effectively mimicking the action of dopamine, a neurotransmitter crucial for motor control, motivation, and pleasure. Pramipexole, a prominent drug synthesized using CAS 106092-11-9, is a powerful example. It is widely prescribed for managing Parkinson's disease, a progressive neurodegenerative disorder that affects movement, and for treating restless legs syndrome, a neurological condition causing an irresistible urge to move the legs. The precise structure of (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole dictates the stereochemistry of Pramipexole, ensuring its targeted action on dopamine receptors.
NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to producing and supplying high-purity (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, understanding its critical role in these therapeutic areas. The chemical properties of this intermediate, including its specific molecular weight (169.25 g/mol) and its typically high purity (≥99.0%), are meticulously controlled to meet the exacting demands of pharmaceutical manufacturing. The ability to buy or purchase this intermediate reliably is key for companies developing next-generation dopamine agonist therapies.
The synthesis pathways utilizing CAS 106092-11-9 are complex, requiring specialized knowledge in organic chemistry and stereoselective synthesis. As a trusted manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. provides not only the chemical itself but also the assurance of quality and consistency that pharmaceutical clients depend on. This commitment underpins the development of safer and more effective treatments for patients suffering from conditions like Parkinson's disease.
For researchers and manufacturers exploring new therapeutic avenues or optimizing existing drug production, understanding the foundational role of intermediates like CAS 106092-11-9 is essential. Partnering with NINGBO INNO PHARMCHEM CO.,LTD. ensures access to a critical component that drives innovation in dopamine agonist therapies.
Perspectives & Insights
Silicon Analyst 88
“is dedicated to producing and supplying high-purity (R)-2,6-Diamino-4,5,6,7-tetrahydrobenzothiazole, understanding its critical role in these therapeutic areas.”
Quantum Seeker Pro
“The chemical properties of this intermediate, including its specific molecular weight (169.”
Bio Reader 7
“0%), are meticulously controlled to meet the exacting demands of pharmaceutical manufacturing.”